 Hoth Therapeutics Inc NASDAQ: HOTH shares are surging after announcing development updates for its novel cancer therapeutic, HT-KIT. Through a sponsored scientific research agreement with North Carolina State University, the team used the HT-KIT mRNA frame-shifting approach on. 